Clinical Trials Logo

Regulatory B Cells clinical trials

View clinical trials related to Regulatory B Cells.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT02891109 Completed - Clinical trials for Purpura, Thrombocytopenic, Idiopathic

Regulatory B Cells and Chronic Immune Thrombocytopenia

PTIREG
Start date: January 2015
Phase: N/A
Study type: Observational

The chronic immune thrombopenia is an autoimmune disease caused by B cells. These cells produce anti platelets and megakaryocytes antibodies. Some B cells, named regulatory B cells, are known to control other cells. Their action in chronic immune thrombopenia is actually unknown.